Xavier Matias-Guiu Guia

Temprana-Salvador J; López-García P; Castellví Vives J; de Haro L; Ballesta E; Rojas Abusleme M; Arrufat M; Marques F; Casas JR; Gallego C; Pons L; Mate JL; Fernández PL; López-Bonet E; Bosch R; Martínez S; Ramón Y Cajal S; Matias-Guiu X

DigiPatICS: Digital Pathology Transformation of the Catalan Health Institute Network of 8 Hospitals-Planification, Implementation, and Preliminary Results.

Diagnostics 12 -. 30/03/2022.

[doi:10.3390/diagnostics12040852]

Mota, A; Oltra, SS; Selenica, P; Moiola, CP; Casas-Arozamena, C; Lopez-Gil, C; Diaz, E; Gatius, S; Ruiz-Miro, M; Calvo, A; Rojo-Sebastian, A; Hurtado, P; Piñeiro R; Colas, E; Gil-Moreno, A; Reis-Filho, JS; Muinelo-Romay, L; Abal, M; Matias-Guiu, X; Weigelt, B; Moreno-Bueno, G

Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression.

ONCOGENE 41 1835-1850. 01/03/2022.

[doi:10.1038/s41388-022-02221-0]

MATIAS-GUIU GUIA, XAVIER

Prevención secundaria de cáncer de cuello de útero, 2022. Conducta clínica ante resultados anormales de las pruebas de cribado

Prevención secundaria del cancer de cuello de útero, 2022. Conducta clínica ante resultados anormales de las pruebas de cribado. -. 01/01/2022.

MORENO, S; MAIQUES, O; Romero M; Santacana M; Gómez I; Cuevas D; Velasco A; Veà À; Macià A; Barceló C; BOIX, R; VALLS, J; GATIUS, S; CANTI, C; MATIAS-GUIU, X; SORIA, X; MARTI, RM

Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification.

ACTA DERMATO-VENEREOLOGICA 101 -. 24/11/2021.

[doi:10.2340/actadv.v101.361]

Rofes P; González S; Navarro M; Moreno-Cabrera JM; Solanes A; Darder E; Carrasco E; Iglesias S; Salinas M; Gómez C; Velasco À; Tuset N; Varela M; Llort G; Ramon Y Cajal T; Grau È; Dueñas N; de la Ossa Merlano N; Matías-Guiu X; Rivera B; Balmaña J; Pineda M; Brunet J; Capellá G; Del Valle J; Lázaro C

Paired Somatic-Germline Testing of 15 Polyposis and Colorectal Cancer-Predisposing Genes Highlights the Role of APC Mosaicism in de Novo Familial Adenomatous Polyposis.

Journal Of Molecular Diagnostics 23 1452-1459. 01/11/2021.

[doi:10.1016/j.jmoldx.2021.07.024]

Soria X; Vilardell F; Maiques Ó; Barceló C; Sisó P; de la Rosa I; Velasco A; Cuevas D; Santacana M; Gatius S; Matías-Guiu X; Rodrigo A; Macià A; Martí RM

BRAF(V600E)

Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics

Cancers 13 -. 11/10/2021.

[doi:10.3390/cancers13205073]

Eritja N; Navaridas R; Ruiz-Mitjana A; Vidal-Sabanés M; Egea J; Encinas M; Matias-Guiu X; Dolcet X

Endometrial PTEN Deficiency Leads to SMAD2/3 Nuclear Translocation

Cancers 13 -. 05/10/2021.

[doi:10.3390/cancers13194990]

Manning-Geist BL; Gatius S; Liu Y; Gil M; Da Cruz Paula A; Tuset N; Abu-Rustum NR; Aghajanian C; Weigelt B; Matias-Guiu X

Diagnosis and management of an endometrial cancer patient with Cowden syndrome.

GYNECOLOGIC ONCOLOGY 163 14-21. 01/10/2021.

[doi:10.1016/j.ygyno.2021.08.008]

Guerra E; Matias-Guiu X

Relevance of pathologic features in risk stratification for early-stage endometrial cancer.

Journal of Gynecologic Oncology 32 -. 01/07/2021.

[doi:10.3802/jgo.2021.32.e67]

Gil-Moreno A; Alonso-Alconada L; Díaz-Feijoo B; Domingo S; Vilar A; Hernández A; Gilabert J; Llueca A; Torné A; de Santiago J; Carbonell-Socias M; Lago V; Arias E; Sampayo V; Siegrist J; Chipirliu A; Sánchez-Iglesias JL; Pérez-Benavente A; Padilla-Iserte P; Santacana M; Matias-Guiu X; Abal M; Lopez-Lopez R

M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients.

GYNECOLOGIC ONCOLOGY 161 681-686. 01/06/2021.

[doi:10.1016/j.ygyno.2021.03.022]

Buza N; Euscher ED; Matias-Guiu X; McHenry A; Oliva E; Ordulu Z; Parra-Herran C; Rottmann D; Turner BM; Wong S; Hui P

Reproducibility of scoring criteria for HER2 immunohistochemistry in endometrial serous carcinoma: a multi-institutional interobserver agreement study.

Modern Pathology 34 1194-1202. 01/06/2021.

[doi:10.1038/s41379-021-00746-5]

Concin N; Matias-Guiu X; Creutzberg CL; ESGO-ESTRO-ESP Endometrial Carcinoma Guideline Working Group

Response to: Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 31 947-947. 01/06/2021.

[doi:10.1136/ijgc-2021-002668]